Systemic Treatments in Localised High Impact Psoriasis

This case study follows the 5-step process for accessing and using evidence in response to a request from the Joint Formulary Group (JFG) in the Bristol, North Somerset, and South Gloucestershire Integrated Care System (BNSSG ICS). A search was conducted to find evidence on the use of certain systemic treatments, namely biologic medications and apremilast, a small molecule drug, in the management of severe psoriasis at localised, high impact sites.

Links and downloads

Systemic Treatments in Localised Psoriasis (.doc, 280kb)

Case studies

Find inspiration for your own evidence search with these real life examples

Guidance

Guidance from a range of organisations for in-depth advice

Services and support

Knowledgeable organisations who may be able to help you

Training resources

Want to learn more? Our training resources are a good place to start